home / stock / bmea / bmea short
Short Information | Biomea Fusion Inc. (NASDAQ:BMEA)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 3,317,273 |
Total Actual Volume | 17,275,595 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 165,864 |
Average Short Percentage | 18.89% |
Is there a BMEA Short Squeeze or Breakout about to happen?
See the BMEA Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
04-30-2024 | $10.66 | $10.74 | $11.125 | $10.56 | 589,833 | 109,337 | 18.54% |
04-29-2024 | $10.86 | $10.75 | $11.16 | $10.615 | 512,171 | 78,725 | 15.37% |
04-26-2024 | $10.57 | $10.78 | $10.9 | $10.39 | 583,288 | 85,635 | 14.68% |
04-25-2024 | $10.53 | $10.47 | $10.55 | $10.26 | 501,987 | 85,626 | 17.06% |
04-24-2024 | $11 | $10.77 | $11.24 | $10.445 | 752,634 | 115,298 | 15.32% |
04-23-2024 | $10.79 | $10.98 | $11.39 | $10.72 | 685,328 | 96,019 | 14.01% |
04-22-2024 | $11.01 | $10.83 | $11.28 | $10.808 | 603,210 | 109,852 | 18.21% |
04-19-2024 | $11.03 | $10.85 | $11.545 | $10.22 | 1,318,800 | 206,487 | 15.66% |
04-18-2024 | $11.41 | $11.16 | $11.87 | $10.95 | 1,671,352 | 222,863 | 13.33% |
04-17-2024 | $12.09 | $11.5 | $12.1 | $11.4401 | 802,858 | 106,608 | 13.28% |
04-16-2024 | $12.4 | $11.95 | $12.58 | $11.79 | 615,837 | 95,939 | 15.58% |
04-15-2024 | $12.88 | $12.51 | $13.37 | $12.11 | 712,858 | 172,780 | 24.24% |
04-12-2024 | $13.23 | $12.98 | $13.66 | $12.64 | 1,031,628 | 246,155 | 23.86% |
04-11-2024 | $12.82 | $13.28 | $13.43 | $12.56 | 786,838 | 206,932 | 26.3% |
04-10-2024 | $12.31 | $12.76 | $12.88 | $12.3 | 791,842 | 190,915 | 24.11% |
04-09-2024 | $12.51 | $12.8 | $12.865 | $12.2 | 858,002 | 178,438 | 20.8% |
04-08-2024 | $12.77 | $12.51 | $12.9835 | $12.42 | 601,199 | 100,275 | 16.68% |
04-05-2024 | $12.61 | $12.73 | $13.28 | $12.01 | 1,218,733 | 320,536 | 26.3% |
04-04-2024 | $14.03 | $12.605 | $14.43 | $12.52 | 1,250,642 | 266,244 | 21.29% |
04-03-2024 | $13 | $13.955 | $13.98 | $13 | 1,386,555 | 322,609 | 23.27% |
News, Short Squeeze, Breakout and More Instantly...
Biomea Fusion Inc. Company Name:
BMEA Stock Symbol:
NASDAQ Market:
REDWOOD CITY, Calif., April 01, 2024 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (Nasdaq: BMEA) (“Biomea” or the “Company”), a clinical stage biopharmaceutical company focused on the discovery and development of covalent small molecules to treat patients with genetically d...
BMF-219 is an investigational novel covalent menin inhibitor developed to regenerate insulin-producing beta cells with the aim to cure diabetes The first two type 1 diabetes patients enrolled in COVALENT-112 both demonstrated early signs of clinical activity with improved measures of be...
In 2023, reported Phase 2 data (COVALENT-111) in type 2 diabetes patients supporting the disease-modifying potential of BMF-219 to address a root cause of diabetes: a loss of healthy, insulin-producing beta cells. After just a 4-week treatment period in type 2 diabetes patients, who had previ...